| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-07 |